Knee cartilage repair: new cell therapy shows promise in small study
NCT ID NCT02539069
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested Chondron, a treatment made from a patient's own cartilage cells, for knee cartilage defects caused by osteoarthritis or injury. Ten participants received the cells during arthroscopic surgery. The study measured pain and knee function over 96 weeks to see if the treatment is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chondron (autologous cultured chondrocytes)
- What this could lead to
- If successful, this could provide a way to repair knee cartilage and reduce pain in people with cartilage defects.
- What could go wrong
- This is a very small, completed post-marketing study with only 10 participants. Results may not apply to everyone, and long-term benefits or risks are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yonsei University Severance Hospital
Seoul, Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Can a new shoulder implant restore arm function where others fail?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Ear cartilage to the rescue? a tiny biopsy could rebuild knees